Get started
Author

Mari I. Suominen

Observed names: M. I. Suominen, M. Suominen, M.I. Suominen, MARI SUOMINEN, Mari I Suominen, Mari Suominen, Suominen, Mari, Suominen, Mari I
Observed institutions: University of Helsinki, University of Turku, Pharmatest (Finland), Institute for Molecular Medicine Finland, Turku Centre for Biotechnology, Bayer (Germany), University of Gothenburg
ORCID: 0000-0002-8760-6595
Observed ORCID: 0000-0002-8760-6595
OpenAlex ID: A5034825484
Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models
2017 · Mari I. Suominen, Katja M. Fagerlund, et al. · Clinical Cancer Research · 181
Secreted Tartrate-Resistant Acid Phosphatase 5b is a Marker of Osteoclast Number in Human Osteoclast Cultures and the Rat Ovariectomy Model
2007 · Jukka P. Rissanen, Mari I. Suominen, et al. · Calcified Tissue International · 149
Survival Benefit With Radium-223 Dichloride in a Mouse Model of Breast Cancer Bone Metastasis
2013 · Mari I. Suominen, Jukka P. Rissanen, et al. · JNCI Journal of the National Cancer Institute · 92
PDF
Improved Statistical Modeling of Tumor Growth and Treatment Effect in Preclinical Animal Studies with Highly Heterogeneous Responses In Vivo
2012 · Teemu D. Laajala, Jukka Corander, et al. · Clinical Cancer Research · 45
PDF
The Mode-of-Action of Targeted Alpha Therapy Radium-223 as an Enabler for Novel Combinations to Treat Patients with Bone Metastasis
2019 · Mari I. Suominen, Timothy Wilson, et al. · International Journal of Molecular Sciences · 37
PDF
Short-Term Changes in Serum PINP Predict Long-Term Changes in Trabecular Bone in the Rat Ovariectomy Model
2008 · Jukka P. Rissanen, Mari I. Suominen, et al. · Calcified Tissue International · 35
Antitumor Activity of Novel Bone-seeking, α-emitting 224Ra-solution in a Breast Cancer Skeletal Metastases Model
2018 · ASTA JUZENIENE, JENNI BERNOULLI, et al. · Anticancer Research · 27
PDF
Efficacy of a HER2-Targeted Thorium-227 Conjugate in a HER2-Positive Breast Cancer Bone Metastasis Model
2023 · Jenny Karlsson, Urs B. Hagemann, et al. · Cancers · 10
PDF
Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer Model
2023 · Mari I. Suominen, Matias Knuuttila, et al. · International Journal of Molecular Sciences · 9
PDF
Human Immune System Increases Breast Cancer-Induced Osteoblastic Bone Growth in a Humanized Mouse Model without Affecting Normal Bone
2019 · Tiina E. Kähkönen, Mari I. Suominen, et al. · Journal of Immunology Research · 8
PDF
Novel and Conventional Preclinical Models to Investigate Bone Metastasis
2019 · Tiina E. Kähkönen, Jenni Bernoulli, et al. · Current Molecular Biology Reports · 6
PDF
Abstract 838: Synergistic in vivo activity of the ATR inhibitor BAY 1895344 in combination with the targeted alpha therapy radium-223 dichloride in a preclinical tumor model mimicking bone metastatic castration-resistant prostate cancer (mCRPC)
2018 · Antje Margret Wengner, Gerhard Siemeister, et al. · Cancer Research · 6
Abstract 5857: HER2-targeted thorium-227 conjugate (HER2-TTC): Efficacy in a HER2 positive orthotopic bone model
2017 · Jenny Karlsson, Urs B. Hagemann, et al. · Cancer Research · 6
Abstract 591: A novel high energy alpha-pharmaceutical: In vitro and in vivo potency of a mesothelin-targeted thorium-227 conjugate (TTC) in a model of bone disease
2016 · Urs B. Hagemann, Else-Marie Hagelin, et al. · Cancer Research · 6
Zoledronic Acid Prevents Bone Resorption Caused by the Combination of Radium-223, Abiraterone Acetate, and Prednisone in an Intratibial Prostate Cancer Mouse Model
2023 · Mari I. Suominen, Matias Knuuttila, et al. · Cancers · 5
PDF
Additive Benefits of Radium-223 Dichloride and Bortezomib Combination in a Systemic Multiple Myeloma Mouse Model
2021 · Mari I. Suominen, Jenni Mäki-Jouppila, et al. · International Journal of Molecular Sciences · 5
PDF
Abstract 5712: Alpharadin (Radium-223 chloride) completely prevents tumor growth in bone and increases survival in a mouse model of breast cancer bone metastases in preventive and micro-metastatic settings
2012 · Mari I. Suominen, Jukka P. Rissanen, et al. · Cancer Research · 5
The anti-tumor agent sagopilone shows antiresorptive effects both in vitro and in vivo
2010 · A. Strube, M. I. Suominen, et al. · Osteoporosis International · 4
Ex vivo expanded adaptive NK cells in combination with a bispecific NK cell engager targeting BCMA for synergistic control of multiple myeloma
2025 · Thorstein Boxaspen, Hannah Cuthbertson Husbyn, et al. · Blood · 3
PDF
Abstract 5043: Radium-223 demonstrates increased antitumor activity in combination with 177Lu-PSMA-617 in the intratibial LNCaP xenograft model of bone metastatic prostate cancer
2023 · Arne Scholz, Matias Knuuttila, et al. · Cancer Research · 3
Humanized mouse models of triple-negative and triple-positive breast cancer for preclinical validation of novel immuno-oncology therapies
2018 · T.E. Kähkönen, M.I. Suominen, et al. · European Journal of Cancer · 3
Abstract 1803: A new spectrum-selective cathepsin inhibitor, VBY-825, inhibits bone destruction in a syngeneic 5TGM1 multiple myeloma mouse model
2014 · Mari I. Suominen, Johanna Tuomela, et al. · Cancer Research · 3
Abstract 49: Comparison of subcutaneous and orthotopic tumor growth in syngeneic mouse models of ovarian and renal cancer
2023 · Mari I. Suominen, Justyna Zdrojewska, et al. · Cancer Research · 2
Abstract 6286: The effects of prednisone, abiraterone acetate and radium-223 dichloride on bone in the intratibial LNCaP prostate cancer model
2020 · Mari I. Suominen, Matias Knuuttila, et al. · Cancer Research · 2
Abstract LB-A01: Establishment of a novel prostate cancer bone metastasis model in humanized mice and early efficacy results of pembrolizumab
2019 · Tiina E Kähkönen, Mari I Suominen, et al. · Molecular Cancer Therapeutics · 2
Works count: 104
Citation count: 671
H-index: 9
I10-index: 8
Year
Topic
Type